Authors:
Sara J. Becker, Bryan R. Garner, Bryan J. Hartzler
University of Washington affiliated authors are displayed in bold.
Subscription Required for Full Text Access
Published: March 2021
Sara J. Becker, Bryan R. Garner, Bryan J. Hartzler
University of Washington affiliated authors are displayed in bold.
Published: March 2021
Claire W. Rothschild, Win Brown, & Alison L. Drake
University of Washington affiliated authors are displayed in bold.
Published: February 2021
While unmet need for contraception is commonly used to assess programmatic needs, it inadequately captures the complexity of fertility and contraceptive preferences, including women's satisfaction with their contraceptive method. In their 2019 commentary, Sarah Rominski and Rob Stephenson propose reclassifying dissatisfied current users as having an unmet need for contraception. As revising the current definition based on their proposal would require significant investment to update survey and monitoring systems, understanding the potential impact on current estimates of unmet need is critical.
We estimated the impact of this approach in a Kenyan cohort of modern contraceptive users. We found the prevalence of method dissatisfaction ranges from 6.6% (95% confidence interval [CI] 5.6–7.8%) to 18.9% (95% CI 17.1–20.9%); if applied nationally, this results in a large (approximately 25–70%) increase in Kenya's current estimate of unmet need for any contraception. Our findings suggest a large impact on unmet need estimates for equivalent populations.
Overall, we advocate for better measurements of method satisfaction and acceptability, with metrics developed that are robust to socioeconomic gradients and validated in low- and middle-income settings to ensure women's contraceptive needs are captured equitably.
**This abstract is posted with permission under the Creative Commons Attribution 4.0 International License**
Katrina F. Ortblad, Peter Mogere, Elizabeth Bukusi, Kenneth Ngure, & Jared M. Baeten
University of Washington affiliated authors are displayed in bold.
Published: September 2020
Several African countries have recently integrated pre‐exposure prophylaxis (PrEP) into their national HIV prevention programmes and are in the process of scaling‐up healthcare facility‐based PrEP delivery. To maximize the public health benefit of PrEP, there is need to prioritize access, minimize the costs of delivery and reach HIV at‐risk populations. Major barriers to facility‐based PrEP delivery exist, including facility‐associated HIV stigma, long waiting times, the costs of staffing and providers’ unfamiliarity with delivering prevention interventions. In Africa, PrEP is also being added to public health infrastructures that are sometimes burdened by overcrowding and drug stock outs. Thus, the ability of African health systems to maximize PrEP access necessitates finding novel models of PrEP delivery.
In low‐resource settings, including a number of African settings, private pharmacies fill an important gap in the medical system and individuals often rely on and prefer the use of pharmacies over healthcare facilities to address their medical needs. Pharmacies can address care needs that are both urgent (e.g. evaluation and medication for sexually transmitted infections) and preventive (e.g. contraception) and have advantages over healthcare facilities, including increased convenience and provider engagement. Compared to providers at healthcare facilities, providers at pharmacies can often spend more time with clients because they do not have to focus on treating sick patients and build better rapport with clients because they are for‐profit businesses that rely on repeat services. In low‐resource settings, it is common for individuals to first go to a pharmacy to address a medical issue (e.g. symptoms of malaria), then only go to a healthcare facility later if the issue is not resolved.
Delivery of PrEP through pharmacies is one approach being utilized in the US to improve PrEP accessibility. In Seattle, the... [READ MORE]
**This abstract is posted with permission under the Creative Commons Attribution 4.0 International License**
Harison Lagat, Monisha Sharma, Edward Kariithi, George Otieno, David Katz, Sarah Masyuko, Mary Mugambi, Beatrice Wamuti, Bryan Weiner & Carey Farquhar
University of Washington affiliated authors are displayed in bold.
Published: June 2020]
Jennifer Leeman, Karen Glanz, Peggy Hannon, & Jackilen Shannon
University of Washington affiliated authors are displayed in bold.
Published: November 2019
Cara C. Lewis, Aaron R. Lyon, Sacha A. McBain, & Sara J. Landes
University of Washington affiliated authors are displayed in bold.
Published: January 2019
Read the full text in the subscription access Journal of Primary Prevention
Herbert B. Peterson, Joumana Haidar, Dean Fixsen, Rohit Ramaswamy, Bryan J. Weiner, Sheila Leatherman
University of Washington affiliated authors are displayed in bold.
Published: March 2018
Jane M Simoni, Frances M Aunon, Christopher G Kemp, Bryan A Kutner, Megan K Ramaiya, Jennifer Velloza, & Joyce P Yang
University of Washington affiliated authors are displayed in bold.
Published: March 2017
Samuel Kalibala, Godfrey B Woelk, Stephen Gloyd, Nrupa Jani, Lynnette Kay, Avina Sarna, Jerry Okal, Charity Ndwiga, Nicole Haberland, & Irit Sinai
University of Washington affiliated authors are displayed in bold.
Published: July 2016
According to UNAIDS, the world currently has an adequate collection of proven HIV prevention, treatment and diagnostic tools, which, if scaled up, can lay the foundation for ending the AIDS epidemic. HIV operations research (OR) tests and promotes the use of interventions that can increase the demand for and supply of these tools. However, current publications of OR mainly focus on outcomes, leaving gaps in reporting of intervention characteristics, which are essential to address for the utilization of OR findings. This has prompted WHO and other international public health agencies to issue reporting requirements for OR studies. The objective of this commentary is to review experiences in HIV OR intervention design, implementation, process data collection and publication in order to identify gaps, contribute to the body of knowledge and propose a way forward to improve the focus on “implementation” in implementation research.
Interventions in OR, like ordinary service delivery programmes, are subject to the programme cycle, which continually uses insights from implementation and the local context to modify service delivery modalities. Given that some of these modifications in the intervention may influence study outcomes, the documentation of process data becomes vital in OR. However, a key challenge is that study resources tend to be skewed towards documentation and the reporting of study outcomes to the detriment of process data, even though process data is vital for understanding factors influencing the outcomes.
Interventions in OR should be viewed using the lens of programme evaluation, which includes formative assessment (to determine concept and design), followed by process evaluation (to monitor inputs and outputs) and effectiveness evaluation (to assess outcomes and effectiveness). Study resources should be equitably used between process evaluation and outcome measurement to facilitate inclusion of data about fidelity and dose in publications in order to enable explanation of the relationship between dosing and study outcomes for purposes of scaling up and further refinement through research.